This Edition
ARTICLE | Clinical News
Bempedoic/ezetimibe: Phase I started
WIR Staff
August 15, 2016 7:00 AM UTC
Esperion began a Phase I trial of 180 mg bempedoic acid/10 mg ezetimibe. ...